Doha:Hamad Medical Corporation (HMC) has opened a new specialized clinic at the National Center for Cancer Care and Research (NCCCR) to support cancer patients who require repeated intravenous treatments. This clinic is designed to provide specialized assessments to determine the most appropriate care method tailored to each patient’s condition and treatment plan.

According to Qatar News Agency, the clinic involves collaboration between oncology and vascular surgery teams from the NCCCR and the Vascular Surgery Department at Hamad General Hospital (HGH). This partnership ensures a comprehensive understanding of each patient’s intravenous treatment needs, aiding in planning and follow-up throughout the treatment process.

The clinic evaluates individual cases to identify the most suitable options for each patient while monitoring their health needs and treatments. This approach helps medical teams anticipate patient needs and avoid delays or complications during treatment.

Dr. Mohammed Salem Al Hassan, Medical Director and CEO of NCCCR and Chairman of Cancer Services at HMC, emphasized the commitment to developing cancer care services to meet patients’ varying needs throughout their treatment journey. He stated that the clinic’s launch is part of these efforts, addressing a critical challenge many patients face during treatment.

Dr. Al Harith Al Khater, Head of Oncology, Palliative Care, and Urgent Care Services at NCCCR, noted that the clinic allows early assessment of patients who need intravenous treatments over extended periods, enabling the medical team to address changing needs as part of the treatment plan.

Dr. Hassan Ali Saud Al-Thani, Head of Trauma, Vascular, and General Surgery Department at HGH, highlighted that some patients have difficulty maintaining suitable venous access for treatment, especially with repeated intravenous treatments. The clinic’s specialized assessments help determine appropriate options based on patients’ needs and treatment nature.

A patient shared their experience, expressing relief after being referred to the clinic. The patient reported that before the referral, accessing veins for chemotherapy was difficult and painful. The clinic team, in collaboration with the Vascular Surgery team, provided a suitable solution, making treatment more comfortable and reducing anxiety.